● Sionna Therapeutics shares have risen to $5.59, up 5.67%, on extraordinarily thin volume, with relativeVolumeof just 0.22.
● Nephros shares have risen to about $4.41, up 8.09%, on elevatedVolumenearly twice its recent norm, extending momentum from a strong quarterly report.
● NervGen Pharma shares have risen to $2.00, up 7.53%, on briskVolumeof about 1.11 million shares, roughly 2.6 times its recent average.
● Kyntra Bio shares have added to $7.98, up 6.12%, on light turnover of about 25,650 shares, with aMarket Valuenear $32.3 million.
● LENSAR shares have risen to $9.23, up 6.34%, on only about 172,000 shares changed hands, roughly half the stock's recent average pace.
● Modular Medical shares have advanced to $3.74, up 5.65%, onVolumeof just under 81,000 shares and an exceptionally low relative volume of 0.11.
● NewcelX shares have closed up 6.05% at $3.46, on extremely light turnover of roughly 6,120 shares and below-average relative volume, in a company with aMarket Valuenear $18.5 million.
● TuHURA Biosciences shares have risen to $2.15, up 7.50%, on light turnover well below the stock's own average, the profile of a low-conviction drift rather than a news-driven surge.
● Janux Therapeutics shares have risen to $18.60, up 6.96%, onVolumeof roughly 1.45 million shares, more than double its recent average.
● HCWBiologicsshares have risen to $2.31, up 5.96%, onVolumeof about 308,000 shares and relative volume of 1.66, in a nano-cap with aMarket Valueof roughly $4.2 million.